Association between Bone Turnover Markers and Fracture Healing in Long Bone Non-Union: A Systematic Review

被引:3
作者
Perut, Francesca [1 ]
Roncuzzi, Laura [1 ]
Gomez-Barrena, Enrique [2 ,3 ]
Baldini, Nicola [1 ,4 ]
机构
[1] IRCCS Ist Ortoped Rizzoli, Biomed Sci & Technol & Nanobiotechnol Lab, I-40136 Bologna, Italy
[2] Hosp Univ La Paz, IdiPAZ, Dept Orthoped Surg & Traumatol, Madrid 28046, Spain
[3] Univ Autonoma Madrid, Fac Med, Madrid 28029, Spain
[4] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40136 Bologna, Italy
关键词
fracture healing; non-union; bone turnover markers; delayed union; prognostic; biomarkers; OSTEOCALCIN; CHALLENGES; MANAGEMENT; RISK; CTX;
D O I
10.3390/jcm13082333
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Fracture healing is a very complex and well-orchestrated regenerative process involving many cell types and molecular pathways. Despite the high efficiency of this process, unsatisfying healing outcomes, such as non-union, occur for approximately 5-10% of long bone fractures. Although there is an obvious need to identify markers to monitor the healing process and to predict a potential failure in callus formation to heal the fracture, circulating bone turnover markers' (BTMs) utility as biomarkers in association with radiographic and clinical examination still lacks evidence so far. Methods: A systematic review on the association between BTMs changes and fracture healing in long bone non-union was performed following PRISMA guidelines. The research papers were identified via the PubMed, Cochrane, Cinahl, Web of Science, Scopus, and Embase databases. Studies in which the failure of fracture healing was associated with osteoporosis or genetic disorders were not included. Results: A total of 172 studies were collected and, given the inclusion criteria, 14 manuscripts were included in this review. Changes in circulating BTMs levels were detected during the healing process and across groups (healed vs. non-union patients and healthy vs. patients with non-union). However, we found high heterogeneity in patients' characteristics (fracture site, gender, and age) and in sample scheduling, which made it impossible to perform a meta-analysis. Conclusions: Clinical findings and radiographic features remain the two important components of non-union diagnosis so far. We suggest improving blood sample standardization and clinical data collection in future research to lay the foundations for the effective use of BTMs as tools for diagnosing non-union.
引用
收藏
页数:15
相关论文
共 51 条
  • [1] Ajai AS Singh., 2013, INT RES J BIOL SCI, V2, P40
  • [2] Ali Sabir, 2019, J Clin Orthop Trauma, V10, pS37, DOI 10.1016/j.jcot.2019.04.026
  • [3] The 'diamond concept' for long bone non-union management
    Andrzejowski, Paul
    Giannoudis, Peter V.
    [J]. JOURNAL OF ORTHOPAEDICS AND TRAUMATOLOGY, 2019, 20 (01)
  • [4] Bone turnover markers to monitor oral bisphosphonate therapy
    Ashcherkin, Nikita
    Patel, Archna A.
    Algeciras-Schimnich, Alicia
    Doshi, Krupa B.
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2023, 90 (01) : 26 - 31
  • [5] Prognostic and therapeutic potential of microRNAs for fracture healing processes and non-union fractures: A systematic review
    Breulmann, Franziska Lioba
    Hatt, Luan Phelipe
    Schmitz, Boris
    Wehrle, Esther
    Richards, Robert Geoff
    Della Bella, Elena
    Stoddart, Martin James
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (01):
  • [6] Bone turnover markers in the management of postmenopausal osteoporosis
    Brown, Jacques P.
    Albert, Caroline
    Nassar, Bassam A.
    Adachi, Jonathan D.
    Cole, David
    Davison, K. Shawn
    Dooley, Kent C.
    Don-Wauchope, Andrew
    Douville, Pierre
    Hanley, David A.
    Jamal, Sophie A.
    Josse, Robert
    Kaiser, Stephanie
    Krahn, John
    Krause, Richard
    Kremer, Richard
    Lepage, Raymond
    Letendre, Elaine
    Morin, Suzanne
    Ooi, Daylily S.
    Papaioaonnou, Alexandra
    Ste-Marie, Louis-Georges
    [J]. CLINICAL BIOCHEMISTRY, 2009, 42 (10-11) : 929 - 942
  • [7] Predicting fracture healing with blood biomarkers: the potential to assess patient risk of fracture nonunion
    Chitwood, Joseph R.
    Chakraborty, Nabarun
    Hammamieh, Rasha
    Moe, Sharon M.
    Chen, Neal X.
    Kacena, Melissa A.
    Natoli, Roman M.
    [J]. BIOMARKERS, 2021, 26 (08) : 703 - 717
  • [8] Bone turnover markers are differentially affected by pre-analytical handling
    Christensen, G. L.
    Halgreen, J. R.
    Milenkovski, M.
    Kose, A.
    Quardon, N.
    Jorgensen, N. R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 (05) : 1137 - 1141
  • [9] Measurement of C-terminal telopeptide of type I collagen (CTX) in serum
    Chubb, S. A. Paul
    [J]. CLINICAL BIOCHEMISTRY, 2012, 45 (12) : 928 - 935
  • [10] A degradation fragment of type X collagen is a real-time marker for bone growth velocity
    Coghlan, Ryan F.
    Oberdorf, Jon A.
    Sienko, Susan
    Aiona, Michael D.
    Boston, Bruce A.
    Connelly, Kara J.
    Bahney, Chelsea
    LaRouche, Jeremie
    Almubarak, Sarah M.
    Coleman, Daniel T.
    Girkontaite, Irute
    von der Mark, Klaus
    Lunstrum, Gregory P.
    Horton, William A.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (419)